Company intelligence / Profile preview

Gary Pharmaceuticals

Ownership: Private
Employees: ~245
Development stage: Commercial

Overview

Gary Pharmaceuticals is an established Indian pharmaceutical manufacturer specializing in dermatology products. The company produces a wide range of topical and oral formulations (creams, ointments, gels, tablets) for various skin conditions. It operates as a cGMP- and ISO-certified contract manufacturing organization with no evidence of proprietary drug discovery or clinical-stage programs.

Modalities: Small molecule
Industry: Contract Manufacturing Organization

Drug pipeline

3 assets

apremilast

Commercial

Indications: Psoriasis

2 more assets in the full pipeline.

Beyond the preview

Go deeper on Gary Pharmaceuticals.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Gary Pharmaceuticals.